Repurposing of Commercially Existing Molecular Target Therapies to Boost the Clinical Efficacy of Immune Checkpoint Blockade

SIMPLE SUMMARY: Epithelial cancers, such as lung, breast, and colon cancers, have high mortality rates because of their ability to spread across multiple organs in the body. Besides the standard of care which includes chemotherapy and radiotherapy, approaches directed to use patient’s own immune res...

Descripción completa

Detalles Bibliográficos
Autores principales: Sinha, Debottam, Moseley, Philip, Lu, Xuehan, Wright, Quentin, Gabrielli, Brian, Frazer, Ian H., Cruz, Jazmina L. G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9776741/
https://www.ncbi.nlm.nih.gov/pubmed/36551637
http://dx.doi.org/10.3390/cancers14246150

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9776741/
https://www.ncbi.nlm.nih.gov/pubmed/36551637
http://dx.doi.org/10.3390/cancers14246150

Ejemplares similares